David Tamang
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Histone Deacetylase Inhibitors Research 16
- Protein Degradation and Inhibitors 12
- Oncology 19
- Peptidase Inhibition and Analysis 11
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Simon S. Jones (15 shared papers)Min Yang (10 shared papers)Noopur Raje (11 shared papers)Peng Wang (1 shared paper)Björn Peters (1 shared paper)Philip E. Bourne (1 shared paper)Alessandro Sette (1 shared paper)C. Lundegaard (1 shared paper)
- Journals
- Blood (10 papers)Cancer Research (6 papers)Public Health Action (3 papers)Clinical Cancer Research (2 papers)Cellular Immunology (2 papers)
- Partner nations
- United StatesSierra LeoneLuxembourg
In The Last Decade
David Tamang
36 papers receiving 1.7k citations
David Tamang's Hit Papers
Peers
Comparison fields: 5 of 82
- Hematology 362
- Oncology 637
- Molecular Biology 1.3k
- Immunology 401
- Infectious Diseases 118
Countries citing papers authored by David Tamang
This map shows the geographic impact of David Tamang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tamang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tamang more than expected).
Fields of papers citing papers by David Tamang
This network shows the impact of papers produced by David Tamang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tamang. The network helps show where David Tamang may publish in the future.
Co-authors
The 25 scholars most cited alongside David Tamang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma Hit paper breakdown → | 2012 | 488 |
| 2 | 2012 | 396 | |
| 3 | 2017 | 192 | |
| 4 | 2016 | 162 | |
| 5 | 2008 | 121 | |
| 6 | 2020 | 83 | |
| 7 | 2006 | 55 | |
| 8 | 2017 | 40 | |
| 9 | 2012 | 31 | |
| 10 | 2016 | 28 | |
| 11 | 2004 | 23 | |
| 12 | 2015 | 20 | |
| 13 | 2015 | 15 | |
| 14 | 2014 | 14 | |
| 15 | 2014 | 10 | |
| 16 | 2017 | 8 | |
| 17 | 2017 | 7 | |
| 18 | 2009 | 7 | |
| 19 | 2020 | 7 | |
| 20 | 2009 | 6 |
About David Tamang
David Tamang is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Cell Biology, having authored 37 papers that have together received 1.8k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (16 papers), Protein Degradation and Inhibitors (12 papers), Multiple Myeloma Research and Treatments (11 papers), Peptidase Inhibition and Analysis (11 papers), Cancer Immunotherapy and Biomarkers (5 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Immune Cell Function and Interaction (3 papers) and Viral Infections and Outbreaks Research (3 papers). The work is most often cited by research in Hematology (362 citations), Oncology (637 citations), Molecular Biology (1.3k citations), Immunology (401 citations) and Infectious Diseases (118 citations). David Tamang has collaborated with scholars based in United States, Sierra Leone and Luxembourg. Frequent co-authors include Simon S. Jones, Min Yang, Noopur Raje, Peng Wang, Björn Peters, Philip E. Bourne, Alessandro Sette, C. Lundegaard, Ole Lund and Zhenggang Zhu. Their work appears in journals such as Blood, Cancer Research, Public Health Action, Clinical Cancer Research and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.